Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

Although biosimilars have been part of clinical practice for more than a decade, healthcare professionals (HCPs) do not fully accept them. This is because of the perception that biosimilars may not be like their originators in terms of quality, safety, and efficacy. This study aims to evaluate the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Halimi, Vesa, Daci, Armond, Ancevska Netkovska, Katerina, Suturkova, Ljubica, Babar, Zaheer-Ud-Din, Grozdanova, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460311/
https://www.ncbi.nlm.nih.gov/pubmed/32796549
http://dx.doi.org/10.3390/ijerph17165800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460311/
https://www.ncbi.nlm.nih.gov/pubmed/32796549
http://dx.doi.org/10.3390/ijerph17165800

Ejemplares similares